14.32
price up icon0.85%   0.12
pre-market  Pre-market:  14.99   0.67   +4.68%
loading
Rxsight Inc stock is traded at $14.32, with a volume of 681.40K. It is up +0.85% in the last 24 hours and down -42.35% over the past month. RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$14.20
Open:
$14.39
24h Volume:
681.40K
Relative Volume:
0.91
Market Cap:
$591.97M
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-17.46
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
-2.05%
1M Performance:
-42.35%
6M Performance:
-71.53%
1Y Performance:
-72.64%
1-Day Range:
Value
$14.06
$14.62
1-Week Range:
Value
$14.01
$14.93
52-Week Range:
Value
$13.50
$66.54

Rxsight Inc Stock (RXST) Company Profile

Name
Name
Rxsight Inc
Name
Phone
949-521-7822
Name
Address
100 COLUMBIA STREET, ALISO VIEJO
Name
Employee
498
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
RXST's Discussions on Twitter

Compare RXST with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
RXST
Rxsight Inc
14.32 591.97M 128.29M -30.69M -27.17M -0.82
Medical Devices icon
ABT
Abbott Laboratories
131.73 218.91B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.05 139.37B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
348.12 134.90B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
83.37 106.90B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
70.60 41.45B 5.72B 4.17B 259.90M 6.97

Rxsight Inc Stock (RXST) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-15-25 Initiated Piper Sandler Neutral
Apr-09-25 Downgrade UBS Buy → Neutral
Apr-04-25 Downgrade JP Morgan Overweight → Underweight
Apr-03-25 Downgrade BofA Securities Buy → Underperform
Dec-20-24 Downgrade Stifel Buy → Hold
Dec-11-24 Downgrade Wells Fargo Overweight → Equal Weight
Dec-06-24 Initiated UBS Buy
Oct-29-24 Initiated Jefferies Buy
Aug-20-24 Reiterated Needham Buy
Aug-06-24 Reiterated Needham Buy
May-07-24 Reiterated BTIG Research Buy
Dec-13-23 Upgrade Wells Fargo Equal Weight → Overweight
Dec-12-23 Initiated Stifel Buy
Dec-04-23 Initiated Morgan Stanley Overweight
Apr-13-23 Initiated Oppenheimer Outperform
Dec-12-22 Downgrade Wells Fargo Overweight → Equal Weight
Apr-08-22 Initiated Needham Buy
View All

Rxsight Inc Stock (RXST) Latest News

pulisher
Apr 22, 2025

LPL Financial LLC Boosts Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World

Apr 22, 2025
pulisher
Apr 18, 2025

Geode Capital Management LLC Has $28.57 Million Stock Position in RxSight, Inc. (NASDAQ:RXST) - Defense World

Apr 18, 2025
pulisher
Apr 15, 2025

Piper Sandler Initiates Coverage of RxSight (RXST) with Neutral Recommendation - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

This Aurora Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

Piper Sandler Initiates RxSight at Neutral With $18 Price Target - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Piper Sandler Begins Coverage of RxSight (RXST) with Neutral Rat - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Piper Sandler sets RxSight stock target at $18, stays neutral By Investing.com - Investing.com South Africa

Apr 15, 2025
pulisher
Apr 15, 2025

Piper Sandler sets RxSight stock target at $18, stays neutral - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

Piper Sandler Starts RxSight Inc. (RXST) at Neutral - StreetInsider

Apr 15, 2025
pulisher
Apr 13, 2025

RxSight price target lowered to $17 from $22 at Wells Fargo - MSN

Apr 13, 2025
pulisher
Apr 11, 2025

RxSight plunges after guidance cut; BofA downgrades - MSN

Apr 11, 2025
pulisher
Apr 10, 2025

RxSight stock plunges to 52-week low at $14.24 amid market challenges By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

RxSight stock plunges to 52-week low at $14.24 amid market challenges - Investing.com

Apr 10, 2025
pulisher
Apr 09, 2025

UBS cuts RxSight stock rating to neutral, slashes price target to $16 By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

RxSight downgraded at UBS after Q1 miss and guidance cut - MSN

Apr 09, 2025
pulisher
Apr 09, 2025

RxSight stock downgraded at UBS on guidance cut (RXST:NASDAQ) - Seeking Alpha

Apr 09, 2025
pulisher
Apr 09, 2025

Needham Cuts Price Target on RxSight to $22 From $43, Keeps Buy Rating - MarketScreener

Apr 09, 2025
pulisher
Apr 09, 2025

UBS Downgrades RxSight to Neutral From Buy, Cuts Price Target to $16 From $45 - MarketScreener

Apr 09, 2025
pulisher
Apr 09, 2025

UBS cuts RxSight stock rating to neutral, slashes price target to $16 - Investing.com Australia

Apr 09, 2025
pulisher
Apr 09, 2025

UBS Downgrades RxSight Inc. (RXST) to Neutral - StreetInsider

Apr 09, 2025
pulisher
Apr 08, 2025

RxSight at Needham Conference: Strategic Adjustments Amid Market Challenges By Investing.com - Investing.com Canada

Apr 08, 2025
pulisher
Apr 07, 2025

Analysts Are Neutral on Top Healthcare Stocks: RxSight (RXST), Johnson & Johnson (JNJ) - The Globe and Mail

Apr 07, 2025
pulisher
Apr 05, 2025

Needham & Company LLC Reiterates “Buy” Rating for RxSight (NASDAQ:RXST) - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

Rxsight adjusts 2025 revenue guidance to $160M-$175M amid premium IOL market challenges - MSN

Apr 05, 2025
pulisher
Apr 04, 2025

Midday Stock Roundup: Masimo, Virgin Galactic an Others Take Dives - Orange County Business Journal

Apr 04, 2025
pulisher
Apr 04, 2025

JP Morgan downgrades RxSight on market, competitive pressures - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

JPMorgan Downgrades RxSight to Underweight From Overweight, Adjusts Price Target to $17 From $40 - MarketScreener

Apr 04, 2025
pulisher
Apr 04, 2025

Deep Dive Into RxSight Stock: Analyst Perspectives (12 Ratings) - Benzinga

Apr 04, 2025
pulisher
Apr 04, 2025

RxSight’s preliminary Q1 2025 revenue expected to increase 28% - Medical Buyer

Apr 04, 2025
pulisher
Apr 04, 2025

American Express, Rxsight, Vertiv Holdings - TradingView

Apr 04, 2025
pulisher
Apr 04, 2025

RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ... By GuruFocus - Investing.com Canada

Apr 04, 2025
pulisher
Apr 04, 2025

JPMorgan Double Downgrades RxSight Inc. (RXST) to Underweight - StreetInsider

Apr 04, 2025
pulisher
Apr 03, 2025

​RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade) - Seeking Alpha

Apr 03, 2025
pulisher
Apr 03, 2025

JPMorgan cuts RxSight stock rating, slashes price target to $17 By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

JPMorgan cuts RxSight stock rating, slashes price target to $17 - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight stock plunges to 52-week low at $15.84 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight stock plunges to 52-week low at $15.84 amid market challenges - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight downgraded to Underweight from Overweight at JPMorgan - TipRanks

Apr 03, 2025
pulisher
Apr 03, 2025

Earnings call transcript: RxSight Q1 2025 sees revenue growth, stock dips By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations - Benzinga

Apr 03, 2025
pulisher
Apr 03, 2025

Biotech Shake-Up: Aldeyra Therapeutics & Others Feel The Heat - Finimize

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight plunges after guidance cut - MSN

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight Plunges 44% After Slashing 2025 Guidance; Bank of America Downgrades Stock - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight Plunges 44% After Slashing 2025 Guidance; Bank of Americ - GuruFocus

Apr 03, 2025
pulisher
Apr 03, 2025

BTIG cuts RxSight stock price target to $28 from $44 By Investing.com - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight stock tumbles on lowered 2025 guidance By Investing.com - Investing.com Canada

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight (RXST) Shares Plummet After Revenue Forecast Cut - GuruFocus

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight stock tumbles on lowered 2025 guidance - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Earnings call transcript: RxSight Q1 2025 sees revenue growth, stock dips - Investing.com Canada

Apr 03, 2025
pulisher
Apr 03, 2025

BTIG cuts RxSight stock price target to $28 from $44 - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight Q1 Revenue Miss, Guidance Cut Raise Growth Concerns, BofA Says - MarketScreener

Apr 03, 2025

Rxsight Inc Stock (RXST) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices ZBH
$97.44
price up icon 1.32%
medical_devices PHG
$24.14
price up icon 3.65%
medical_devices STE
$222.77
price up icon 1.82%
$66.33
price up icon 0.33%
$61.65
price up icon 1.93%
medical_devices EW
$70.60
price up icon 2.02%
Cap:     |  Volume (24h):